61858-39-7

Usage

Uses

2-amino-1-(3-bromophenyl)ethanone, HCl

Upstream product

• 681004-52-4 2-azido-1-(3'-bromophenyl)ethanone 
• 18523-22-3 2,3'-dibromoacetophenone 
• 125910-14-7 (3-bromo-phenyl)-glyoxal-2-oxime 

Downstream Products

• 1171113-42-0 3-bromo-N-[2-(3-bromophenyl)-2-oxoethyl]-2,2-diethoxypropanamide 
• 1333432-91-9 C₂₁H₂₃BrN₂O₆ 
• 1171113-66-8 2-bromo-1-[5-(3-bromophenyl)oxazol-2-yl]ethanone 
• 1171113-54-4 2-(2-bromo-1,1-diethoxyethyl)-5-(3-bromophenyl)oxazole 

Relevant academic research and scientific papers

The reaction of prop-2-ynylsulfonium salts and sulfonyl-protected β-amino ketones to epoxide-fused 2-methylenepyrrolidines and S-containing pyrroles

A novel divergent domino annulation reaction of prop-2-ynylsulfonium salts with sulfonyl-protected β-amino ketones has been developed, affording various epoxide-fused 2-methylenepyrrolidines and S-containing pyrroles in moderate to excellent yields. Prop-2-ynylsulfonium salts act as C2synthons in the reactions providing a promising epoxide-fused skeleton in a single operation with readily accessible starting materials.

HEPATITIS C VIRUS INHIBITORS

This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.

1,2,4-Triazin-3(2H) ones

Heterocyclic compounds of the formula STR1 wherein either X is --CR1 R2 and Y is --O--, --S-- or --NR3 --, wherein R1, R2 and R3, which may be the same or different, each is hydrogen or alk

1,3,4-Thiadiazin-2-ones

Heterocyclic compounds of the formula STR1 wherein either X is --CR1 R2 and Y is --O--, --S-- or --NR3 --, wherein R1, R2 and R3, which may be the same or different, each is hydrogen or alk